Cargando…
Ginsenoside-Rb1 targets chemotherapy-resistant ovarian cancer stem cells via simultaneous inhibition of Wnt/β-catenin signaling and epithelial-to-mesenchymal transition
Chemoresistance is a major clinical problem compromising the successful treatment of cancer. One exciting approach is the eradication of cancer stem/tumor-initiating cells (jointly CSCs), which account for tumor initiation, progression, and drug resistance. Here we show for the first time, with mech...
Autores principales: | Deng, Shan, Wong, Chris Kong Chu, Lai, Hung-Cheng, Wong, Alice Sze Tsai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432225/ https://www.ncbi.nlm.nih.gov/pubmed/27825116 http://dx.doi.org/10.18632/oncotarget.13071 |
Ejemplares similares
-
Ginsenoside Rb1 ameliorates CKD‐associated vascular calcification by inhibiting the Wnt/β‐catenin pathway
por: Zhou, Peng, et al.
Publicado: (2019) -
Ginsenoside Rb1 inhibits hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells by regulating microRNA-25
por: Liu, Dan, et al.
Publicado: (2017) -
Ginsenoside Rb1 Facilitates Browning by Repressing Wnt/β-Catenin Signaling in 3T3-L1 Adipocytes
por: Fan, Qingxin, et al.
Publicado: (2021) -
Linc-ROR induces epithelial-to-mesenchymal transition in ovarian cancer by increasing Wnt/β-catenin signaling
por: Lou, Yanhui, et al.
Publicado: (2017) -
Pharmacology of ginsenosides: a literature review
por: Leung, Kar Wah, et al.
Publicado: (2010)